Literature DB >> 22905841

Remote monitoring of cardiovascular implanted electronic devices: a paradigm shift for the 21st century.

Edmond M Cronin1, Niraj Varma.   

Abstract

Traditional follow-up of cardiac implantable electronic devices involves the intermittent download of largely nonactionable data. Remote monitoring represents a paradigm shift from episodic office-based follow-up to continuous monitoring of device performance and patient and disease state. This lessens device clinical burden and may also lead to cost savings, although data on economic impact are only beginning to emerge. Remote monitoring technology has the potential to improve the outcomes through earlier detection of arrhythmias and compromised device integrity, and possibly predict heart failure hospitalizations through integration of heart failure diagnostics and hemodynamic monitors. Remote monitoring platforms are also huge databases of patients and devices, offering unprecedented opportunities to investigate real-world outcomes. Here, the current status of the field is described and future directions are predicted.

Entities:  

Mesh:

Year:  2012        PMID: 22905841     DOI: 10.1586/erd.12.18

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  9 in total

Review 1.  Heart failure as a substrate and trigger for ventricular tachycardia.

Authors:  Chikezie K Alvarez; Edmond Cronin; William L Baker; Jeffrey Kluger
Journal:  J Interv Card Electrophysiol       Date:  2019-10-09       Impact factor: 1.900

2.  Patients' experiences of remote communication after pacemaker implant: The NORDLAND study.

Authors:  Daniel Catalan-Matamoros; Antonio Lopez-Villegas; Knut Tore-Lappegard; Remedios Lopez-Liria
Journal:  PLoS One       Date:  2019-06-20       Impact factor: 3.240

3.  Construction and application of service quality evaluation system in the preclinical research on cardiovascular implant devices.

Authors:  Yongchun Cui; Fuliang Luo; Boqing Yang; Bin Li; Qi Zhang; Gopika Das; Guangxin Yue; Jiajie Li; Yue Tang; Xin Wang
Journal:  BMC Med Inform Decis Mak       Date:  2019-02-28       Impact factor: 2.796

4.  Effectiveness and Safety in Remote Monitoring of Patients with Pacemakers Five Years after an Implant: The Poniente Study.

Authors:  Remedios López-Liria; Antonio López-Villegas; César Leal-Costa; Salvador Peiró; Emilio Robles-Musso; Rafael Bautista-Mesa; Patricia Rocamora-Pérez; Knut Tore Lappegård; Daniel Catalán-Matamoros
Journal:  Int J Environ Res Public Health       Date:  2020-02-23       Impact factor: 3.390

5.  Cost-utility analysis of telemonitoring versus conventional hospital-based follow-up of patients with pacemakers. The NORDLAND randomized clinical trial.

Authors:  Antonio Lopez-Villegas; Daniel Catalan-Matamoros; Salvador Peiro; Knut Tore Lappegard; Remedios Lopez-Liria
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

Review 6.  Knowledge Update on the Economic Evaluation of Pacemaker Telemonitoring Systems.

Authors:  Antonio Lopez-Villegas; César Leal-Costa; Mercedes Perez-Heredia; Irene Villegas-Tripiana; Daniel Catalán-Matamoros
Journal:  Int J Environ Res Public Health       Date:  2021-11-18       Impact factor: 3.390

Review 7.  Mechanical Sensors for Cardiovascular Monitoring: From Battery-Powered to Self-Powered.

Authors:  Chuyu Tang; Zhirong Liu; Linlin Li
Journal:  Biosensors (Basel)       Date:  2022-08-17

8.  Health-related quality of life on tele-monitoring for users with pacemakers 6 months after implant: the NORDLAND study, a randomized trial.

Authors:  Antonio Lopez-Villegas; Daniel Catalan-Matamoros; Remedios Lopez-Liria; Terje Enebakk; Hilde Thunhaug; Knut Tore Lappegård
Journal:  BMC Geriatr       Date:  2018-09-21       Impact factor: 3.921

9.  Long-term cost-utility analysis of remote monitoring of older patients with pacemakers: the PONIENTE study.

Authors:  Rafael Jesus Bautista-Mesa; Antonio Lopez-Villegas; Salvador Peiro; Daniel Catalan-Matamoros; Emilio Robles-Musso; Remedios Lopez-Liria; Cesar Leal-Costa
Journal:  BMC Geriatr       Date:  2020-11-16       Impact factor: 3.921

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.